Skip to main content
Premium Trial:

Request an Annual Quote

Alpha Innotech, Schleicher & Schuell BioScience, Drug and Market Development Publications, Blueprint Initiative

Premium

Alpha Innotech of San Leandro, Calif., last week released its Fluor Chem 5500 Imaging System. The instrument can be used for visible light imaging of 1D and 2D gels, as well as for a variety of other visible light, fluorescent, and chemiluminescent applications.

The system increases resolution to over 1.1 million pixels and uses noise reduction algorithms to increase the signal-to-noise ratio for a 12-bit dynamic range. It also documents, archives, and analyzes the samples.


Schleicher & Schuell BioScience of Keene, NH, this week launched its FAST Frame multi-slide plate for high-throughput processing of microarrays. It is designed for use with 16-pad FAST Slides and the slides' corresponding 16-well incubation chambers.

The plate can process 64 arrays at a time and is compatible with typical automated liquid handling systems and with eight-channel manual pipettors.


Drug and Market Development Publications this week released a report entitled Protein Arrays: Commercial Opportunities, Legal Trends, and Technology Analyses, in which it announced that it expects the protein array market to grow by 85 percent between now and 2006. Its market analysis, among other topics, examines the differences between market potentials for high-density and low-density arrays, the trend among protein array companies to become more product-focused, and the issue of intellectual property ownership. The complete report is available at www.drugandmarket.com.


 

The Blueprint Initiative of Toronto announced last week that it had upgraded its Biomolecular Interaction Network Database and software. Upgrades to the BIND Data Manager web software include an improved linking structure for accessing BIND data, improved visualization for mass spec-derived interactions, and the integration of BIND text queries with the PreBIND text mining system.

Additional changes to BIND include the following: BIND will be broken into three divisions based on the molecule’s source organism to make the system’s size more manageable, BIND datasets will be provided on the ftp site for comparative analysis, and datasets will be divided into three categories — publication, experimental system, and taxonomy.

In addition, with one universal accession space, only one set of accession numbers will now be used for the three different types of BIND data records: interactions, complexes, and pathways.

 

The Scan

Booster for At-Risk

The New York Times reports that the US Food and Drug Administration has authorized a third dose of the Pfizer-BioNTech SARS-CoV-2 vaccine for people over 65 or at increased risk.

Preprints OK to Mention Again

Nature News reports the Australian Research Council has changed its new policy and now allows preprints to be cited in grant applications.

Hundreds of Millions More to Share

The US plans to purchase and donate 500 million additional SARS-CoV-2 vaccine doses, according to the Washington Post.

Nature Papers Examine Molecular Program Differences Influencing Neural Cells, Population History of Polynesia

In Nature this week: changes in molecular program during embryonic development leads to different neural cell types, and more.